PDF is committed to using your funds efficiently to support our mission. To see how funds are spent, browse our financial information.
PDF to Webcast 50th Anniversary Symposium on Parkinsonís Disease
To commemorate 50 years of service to the Parkinson’s community, the Parkinson’s Disease Foundation (PDF) will present a comprehensive round-up of the state of Parkinson’s science at a two-day symposium on October 11 and 12. The jam-packed program will be webcast live and will feature over 40 top-notch Parkinson’s professionals presenting the latest news in Parkinson’s science and quality of life initiatives.
The meeting, entitled Frontiers of Science and Clinical Advances in Quality of Life, will be attended by Parkinson’s researchers, clinicians, allied health professionals, people with Parkinson’s disease and caregivers.
The program, in two parallel tracks, will look at the progress that has been made over the last 10 years and where we expect to see future advances.
The basic science track for the symposium was planned by an expert committee chaired by Dr. Stanley Fahn of Columbia University, who also serves as PDF’s Scientific Director. The committee identified the hottest topics in Parkinson’s science including genetics, neurobiology, pathology, gene therapy and cell replacement.
Parkinson’s science does not end in the laboratory. It also includes examination of how people can live better with the disease. This is the focus of a second expert committee headed by Drs. Lucien Côté and Karen Marder, both of Columbia University. Among the topics addressed are the preclinical diagnosis of Parkinson’s disease; respiratory, gastrointestinal and sexual issues; sleep disorders; caregiver support and the therapeutic effect of exercise.
We hope that you will log on to our webcast of this in-depth review of Parkinson’s science. For more information on the webcast and to register, visit www.pdf.org/en/50th_Symposium. The webcast will be available on the PDF site following the symposium for one year.
This webcast is supported exclusively by HealthShares.